Korro Bio (KRRO) Common Equity (2019 - 2025)
Historic Common Equity for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $99.0 million.
- Korro Bio's Common Equity fell 4486.95% to $99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.0 million, marking a year-over-year decrease of 4486.95%. This contributed to the annual value of $160.4 million for FY2024, which is 558.88% down from last year.
- As of Q3 2025, Korro Bio's Common Equity stood at $99.0 million, which was down 4486.95% from $115.1 million recorded in Q2 2025.
- In the past 5 years, Korro Bio's Common Equity registered a high of $198.1 million during Q2 2024, and its lowest value of -$99.0 million during Q4 2022.
- Moreover, its 5-year median value for Common Equity was $130.8 million (2021), whereas its average is $113.7 million.
- Its Common Equity has fluctuated over the past 5 years, first crashed by 17569.79% in 2022, then skyrocketed by 38896.75% in 2024.
- Korro Bio's Common Equity (Quarter) stood at $130.8 million in 2021, then plummeted by 175.7% to -$99.0 million in 2022, then soared by 271.57% to $169.9 million in 2023, then dropped by 5.59% to $160.4 million in 2024, then plummeted by 38.27% to $99.0 million in 2025.
- Its Common Equity stands at $99.0 million for Q3 2025, versus $115.1 million for Q2 2025 and $139.0 million for Q1 2025.